Burning Rock Biotech
(NASDAQ) BNR
Burning Rock Biotech Financials at a Glance
Market Cap
$146.35M
Revenue (TTM)
$537.82M
Net Income (TTM)
$55.13M
EPS (TTM)
$-0.72
P/E Ratio
-22.46
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$16.36
Volume
55,936.971
Open
$16.79
Price
$16.36
Volume
55,936.971
Open
$16.79
Previous Close
$16.20
Daily Range
$16.20 - $17.05
52-Week Range
$2.18 - $41.72
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$16.36
Volume
55,936.971
Open
$16.79
Previous Close
$16.20
Daily Range
$16.20 - $17.05
52-Week Range
$2.18 - $41.72
BNR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Burning Rock Biotech
Industry
Biotechnology
Sector
Health CareEmployees
674
CEO
Yu Sheng Han, MBA
Website
www.brbiotech.comHeadquarters
Guangzhou, 510005, CN
BNR Financials
Key Financial Metrics (TTM)
Gross Margin
75%
Operating Margin
-10%
Net Income Margin
-10%
Return on Equity
-10%
Return on Capital
-10%
Return on Assets
-7%
Earnings Yield
-4.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$146.35M
Shares Outstanding
9.03M
Volume
55.94K
Short Interest
0.00%
Avg. Volume
29.30K
Financials (TTM)
Gross Profit
$391.94M
Operating Income
$53.35M
EBITDA
$43.05M
Operating Cash Flow
$92.26M
Capital Expenditure
$5.98M
Free Cash Flow
$98.24M
Cash & ST Invst.
$481.39M
Total Debt
$43.15M
Burning Rock Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$124.57M
-1.2%
Gross Profit
$97.21M
+8.7%
Gross Margin
78.03%
N/A
Market Cap
$146.35M
N/A
Market Cap/Employee
$217.14K
N/A
Employees
674
N/A
Net Income
$15.17M
+81.3%
EBITDA
$9.06M
+80.6%
Quarterly Fundamentals
Net Cash
$438.25M
-6.3%
Accounts Receivable
$182.03M
+4.9%
Inventory
$57.01M
+6.0%
Long Term Debt
$26.17M
-5.7%
Short Term Debt
$16.97M
-30.9%
Return on Assets
-6.72%
N/A
Return on Invested Capital
-9.53%
N/A
Free Cash Flow
$16.39M
+154.1%
Operating Cash Flow
$16.39M
+154.1%